Cai Lay Veterinary Pharmaceutical JSC (HNX:MKV)
Vietnam · Delayed Price · Currency is VND 21,500
-900 (-4.02%)
At close: Jan 30, 2026
HNX:MKV Revenue
In the year 2025, Cai Lay Veterinary Pharmaceutical JSC had annual revenue of 148.87B VND with 39.08% growth. Cai Lay Veterinary Pharmaceutical JSC had revenue of 39.47B in the quarter ending December 31, 2025, with 59.52% growth.
Revenue
148.87B
Revenue Growth
+39.08%
P/S Ratio
0.76
Revenue / Employee
1.43B
Employees
104
Market Cap
112.50B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 148.87B | 41.83B | 39.08% |
| Dec 31, 2024 | 107.04B | -3.87B | -3.49% |
| Dec 31, 2023 | 110.91B | -8.73B | -7.30% |
| Dec 31, 2022 | 119.63B | 17.22B | 16.82% |
| Dec 31, 2019 | 102.41B | -32.17B | -23.90% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Domesco Medical Import - Export Joint-Stock | 2.08T |
| Vimedimex Medi-Pharma JSC | 1.17T |
| OPC Pharmaceutical JSC | 1.06T |
| Vidipha Central Pharmaceutical JSC | 950.89B |
| Ben Tre Pharmaceutical JSC | 839.79B |
| Pharmedic Pharmaceutical Medicinal JSC | 546.57B |
| Central Pharmaceutical Joint Stock Company No3 | 438.01B |
| Mediplantex National Pharmaceutical JSC | 367.08B |